ANTI-GANGLIOSIDE ANTIBODIES - ANVISA Registration 80102513258
Access comprehensive regulatory information for ANTI-GANGLIOSIDE ANTIBODIES in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102513258 and manufactured by BUHLMANN LABORATORIES AG. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 2 companies making the same product including BUHLMANN LABORATORIES AG, EUROIMMUN AG, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80102513258
25351317300202451
04718143000194
Company Information
Dates and Status
Jul 08, 2024
VIGENTE
09/18/2025 19:00:01
ANTICORPOS ANTI-GANGLIOSÍDEO
BÜHLMANN GanglioCombi MAG ELISA
BUHLMANN LABORATORIES AG
80102512135
Oct 29, 2018
ANTICORPOS ANTI-GANGLIOSÍDEO
BÜHLMANN GanglioCombi Light ELISA
BUHLMANN LABORATORIES AG
80102512136
Oct 29, 2018
ANTICORPOS ANTI-GANGLIOSÍDEO
EUROLINE: Perfil gangliosídeos 2 (IgM)
EUROIMMUN AG
81148560038
Dec 12, 2016
ANTICORPOS ANTI-GANGLIOSÍDEO
EUROLINE: Perfil gangliosídeos 2 (IgG)
EUROIMMUN AG
81148560037
Nov 07, 2016

